"use client"

import { useState, useEffect } from "react"
import { AlertCircle } from "lucide-react"
import { Header } from "@/components/header"
import { BriefInput } from "@/components/brief-input"
import { ResultsSection } from "@/components/results-section"
import { LoadingSkeleton } from "@/components/loading-skeleton"
import { EmptyState } from "@/components/empty-state"
import { FormatLibrary } from "@/components/format-library"
import { Alert, AlertDescription, AlertTitle } from "@/components/ui/alert"
import { Button } from "@/components/ui/button"
import {
  DEFAULT_FORMATS,
  DEFAULT_DIAGNOSTIC_RULES,
  SAMPLE_RESEARCH_DOCUMENTS,
} from "@/lib/mock-data"
import type {
  GenerationResult,
  ChallengeFormat,
  DiagnosticRule,
  ResearchDocument,
} from "@/lib/types"

type AppState = "idle" | "loading" | "success" | "error"

// Pre-Launch Marketing Brief using structured format
const SAMPLE_BRIEF = `CLIENT MARKETING BRIEF
(Pre-Creative / Pre-Agency Brief â€” Pre-Launch)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

1. BRAND STATUS

Brand / Product Name: Velozia (enzalutinib)

Lifecycle Stage: Pre-Launch (Approval expected: September 2026)

Pre-Launch Details:
â€¢ Indication under review: First-line treatment for adults with EGFR-mutated metastatic NSCLC
â€¢ Expected label scope: Oral, once-daily targeted therapy with CNS penetration claims
â€¢ Key regulatory milestones:
  - FDA Advisory Committee: July 2026
  - PDUFA date: September 2026
  - EU filing: Q4 2026

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

2. BACKGROUND & BUSINESS CONTEXT

Category Context:
â€¢ Tagrisso (osimertinib) dominates with 62% market share and $5.2B annual revenue
â€¢ EGFR TKI category perceived as mature with established treatment paradigms
â€¢ Brain metastases present in 25-40% of EGFR+ patientsâ€”a critical unmet need
â€¢ Increasing payer scrutiny on high-cost oncology therapies
â€¢ NCCN guidelines heavily favor Tagrisso as first-line standard

Brand Context (Pre-Launch):
â€¢ Intended role in therapy: Confident first-line alternative with superior CNS protection
â€¢ Strategic reason for entering now:
  - Phase 3 data shows 18.9 months PFS vs 10.2 months SOC
  - CNS efficacy data is category-leading (24.3 months CNS-PFS)
  - Better tolerability profile (28% Grade 3+ AEs vs 41% for competitors)
  - Competitive pricing strategy (15% below Tagrisso)

Why This Matters Now:
â€¢ Launch window requires clear differentiation before being dismissed as "another TKI"
â€¢ Tagrisso's 8-year head start means HCP habits are deeply entrenched
â€¢ Must establish CNS protection story before competitors address this gap

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

3. THE CORE BUSINESS PROBLEM

Pre-Launch Framing:
â€¢ How do we enter a market where Tagrisso is the reflexive first choice?
â€¢ How do we make CNS protection a decision-driver, not a nice-to-have?
â€¢ How do we establish credibility with oncologists who have no relationship with Meridian Biopharmaceuticals?
â€¢ How do we avoid being positioned as "Tagrisso-lite" or a second-line fallback?

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

4. OBJECTIVES

Primary Objective:
â€¢ Establish a distinct, credible launch positioning centered on CNS protection
â€¢ Drive early HCP consideration and formulary readiness

Secondary Objectives:
â€¢ Shape perception of Velozia as "the thinking oncologist's choice"
â€¢ Equip 180 oncology specialists with a confident, focused launch story
â€¢ Build advocacy network of 50+ KOLs before commercial availability
â€¢ Achieve 8% market share by end of Year 1 ($420M revenue)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

5. TARGET AUDIENCE

Primary Audience:
â€¢ Medical oncologists specializing in thoracic malignancies
â€¢ High-volume community oncologists (12+ EGFR+ patients/month)
â€¢ Academic oncologists at NCI-designated cancer centers

Audience Nuance (Pre-Launch):
â€¢ Education and mindset shaping requiredâ€”many oncologists underestimate brain metastasis risk
â€¢ Need to reach both early adopters AND thoughtful conservatives
â€¢ Must prepare the market for a new option without creating confusion

Secondary Audiences:
â€¢ Pulmonologists involved in early-stage diagnosis
â€¢ Oncology nurse navigators influencing treatment discussions
â€¢ Hospital pharmacists managing formulary decisions

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

6. ANTICIPATED BRAND PERCEPTION (Pre-Launch)

What we believe HCPs will assume about us at launch:
â€¢ "Another EGFR TKIâ€”what's the difference?"
â€¢ "Probably works, but why switch from what I know?"
â€¢ "Smaller company, less support infrastructure"
â€¢ "CNS data sounds good, but Tagrisso works fine for my patients"

Category stereotypes we risk inheriting:
â€¢ New entrants are often seen as "me-too" until proven otherwise
â€¢ Smaller companies perceived as less reliable for long-term support
â€¢ Oral TKIs all blend together in crowded category

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

7. KEY INSIGHTS (Directional)

Clinical Tensions:
â€¢ Brain metastases remain the silent fear in EGFR+ NSCLCâ€”progression often means cognitive decline
â€¢ Many oncologists don't proactively discuss CNS risk until symptoms appear
â€¢ Tolerability matters more than HCPs admitâ€”dose modifications disrupt patient confidence

Decision-Making Pressures:
â€¢ Time-starved oncologists default to familiar agents
â€¢ Guideline adherence is a safety net; deviation requires justification
â€¢ Payer restrictions increasingly dictate first-line choices

Unmet Needs Not Fully Addressed:
â€¢ Proactive CNS protection is discussed but rarely acted upon
â€¢ Patients want to "stay on therapy longer" without debilitating side effects
â€¢ HCPs want confidence, not just dataâ€”reassurance that they're making the right call

(Insights are hypotheses, not truthsâ€”agency validation expected.)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

8. POSITIONING (Status)

Status: No formal positioning exists; agency to develop

Positioning Considerations:
â€¢ Intended role: Confident first-line alternative for oncologists who prioritize CNS protection
â€¢ Degree of differentiation: Moderate-to-high, but must be credibility-first
â€¢ Must balance clinical ambition with launch-appropriate restraint
â€¢ Elements that must remain consistent: CNS efficacy story, tolerability advantage

Working direction (not final):
"For oncologists who refuse to wait for brain metastases to become a problem."

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

9. MANDATORIES & GUARDRAILS

Regulatory:
â€¢ Approved indication language pendingâ€”first-line EGFR+ mNSCLC expected
â€¢ CNS claims permitted based on secondary endpoint data
â€¢ No direct comparative superiority claims vs. Tagrisso at launch

Brand:
â€¢ Meridian Biopharmaceuticals brand standards apply
â€¢ Scientific, confident toneâ€”avoid fear-based messaging
â€¢ Visual identity in development; agency input welcome

What to Avoid:
â€¢ Over-promising efficacy before long-term data available
â€¢ Fear-based brain metastasis messaging that alarms patients
â€¢ Aggressive competitive positioning that invites backlash
â€¢ Lifestyle or patient journey storytelling (HCP-focused campaign)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

10. DELIVERABLES (Pre-Launch)

â€¢ Launch campaign territory and creative platform
â€¢ Core visual and narrative system
â€¢ Disease education framework (CNS risk in EGFR+ NSCLC)
â€¢ Brand introduction materials for HCPs
â€¢ Sales force training and message pull-through
â€¢ Congress presence strategy (ASCO, ESMO)
â€¢ Digital HCP engagement platform foundation

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

11. TIMING & MILESTONES

â€¢ Agency briefing: January 2026
â€¢ Concept development: February-March 2026
â€¢ Advisory board meetings with top 30 KOLs: May 2026
â€¢ ASCO presentation of Phase 3 data: July 2026
â€¢ Internal/legal review cycles: Ongoing
â€¢ FDA approval (anticipated): September 2026
â€¢ Launch week activities: September 2026
â€¢ Payer contracting completion: Q4 2026

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

12. SUCCESS METRICS

Pre-Launch:
â€¢ Message clarity and recall in launch research (target: 70%+ unaided recall of CNS story)
â€¢ Sales force readiness scores (target: 90% confident in core message delivery)
â€¢ Early awareness among target oncologists (target: 65% aided awareness by launch)
â€¢ KOL advocacy network (target: 50+ engaged advocates)

Year 1 Post-Launch:
â€¢ Market share: 8% by end of Year 1
â€¢ New patient starts: Track monthly velocity
â€¢ Formulary access: Tier 2 or better with 80% of commercial lives
â€¢ NCCN Guideline inclusion: Category 1 recommendation`

export default function BrainstormAgent() {
  // Start with empty brief - users select from brand selector or paste their own
  const [briefText, setBriefText] = useState("")
  const [appState, setAppState] = useState<AppState>("idle")
  const [result, setResult] = useState<GenerationResult | null>(null)
  const [error, setError] = useState<string | null>(null)
  const [isLibraryOpen, setIsLibraryOpen] = useState(false)
  const [formats, setFormats] = useState<ChallengeFormat[]>(DEFAULT_FORMATS)
  const [diagnosticRules, setDiagnosticRules] =
    useState<DiagnosticRule[]>(DEFAULT_DIAGNOSTIC_RULES)

  // Research Library state
  const [researchDocuments, setResearchDocuments] = useState<ResearchDocument[]>(
    SAMPLE_RESEARCH_DOCUMENTS
  )
  const [selectedResearch, setSelectedResearch] = useState<string[]>([])

  // Load formats from localStorage on mount
  useEffect(() => {
    const savedFormats = localStorage.getItem("brainstorm-formats")
    const savedRules = localStorage.getItem("brainstorm-rules")

    if (savedFormats) {
      try {
        setFormats(JSON.parse(savedFormats))
      } catch {
        // Use defaults if parse fails
      }
    }

    if (savedRules) {
      try {
        setDiagnosticRules(JSON.parse(savedRules))
      } catch {
        // Use defaults if parse fails
      }
    }
  }, [])

  // Save formats to localStorage when updated
  const handleUpdateFormats = (newFormats: ChallengeFormat[]) => {
    setFormats(newFormats)
    localStorage.setItem("brainstorm-formats", JSON.stringify(newFormats))
  }

  const handleUpdateRules = (newRules: DiagnosticRule[]) => {
    setDiagnosticRules(newRules)
    localStorage.setItem("brainstorm-rules", JSON.stringify(newRules))
  }

  // Research library handlers
  const handleToggleResearch = (docId: string) => {
    setSelectedResearch((prev) =>
      prev.includes(docId)
        ? prev.filter((id) => id !== docId)
        : [...prev, docId]
    )
  }

  const handleSelectAllResearch = () => {
    setSelectedResearch(researchDocuments.map((d) => d.id))
  }

  const handleClearAllResearch = () => {
    setSelectedResearch([])
  }

  const handleAddResearchDocument = (doc: ResearchDocument) => {
    setResearchDocuments((prev) => [...prev, doc])
  }

  const handleRemoveResearchDocument = (docId: string) => {
    setResearchDocuments((prev) => prev.filter((d) => d.id !== docId))
    setSelectedResearch((prev) => prev.filter((id) => id !== docId))
  }

  const handleGenerate = async (includeResearch: boolean) => {
    setAppState("loading")
    setError(null)

    try {
      console.log("ğŸš€ Starting generation request...")
      const controller = new AbortController()
      const timeoutId = setTimeout(() => controller.abort(), 60000)

      console.log("ğŸ“¡ Sending POST to /api/generate-challenge-statements")
      const response = await fetch('http://localhost:8000/api/generate-challenge-statements', {
        method: 'POST',
        headers: {
          'Content-Type': 'application/json',
        },
        body: JSON.stringify({
          brief_text: briefText,
          include_research: includeResearch,
          selected_research_ids: includeResearch ? selectedResearch : null
        }),
        signal: controller.signal
      })

      clearTimeout(timeoutId)
      console.log(`ğŸ“¥ Response status: ${response.status}`)

      if (!response.ok) {
        const errorData = await response.json().catch(() => ({}))
        throw new Error(
          errorData.detail || `API request failed with status ${response.status}`
        )
      }

      const data = await response.json()

      // Transform API response to match frontend format
      const result = {
        challenge_statements: data.challenge_statements,
        diagnostic_summary: data.diagnostic_summary,
        diagnostic_path: data.diagnostic_path
      }

      setResult(result)
      setAppState("success")
    } catch (err) {
      console.error("ğŸš¨ Generation failed:", err)

      let errorMessage = "An unexpected error occurred"
      if (err instanceof Error) {
        if (err.name === 'AbortError') {
          errorMessage = "Request timed out after 60 seconds. The model might be busy."
        } else {
          errorMessage = err.message
        }
      }

      setError(errorMessage)
      setAppState("error")
    }
  }

  const handleReset = () => {
    setBriefText("")
    setResult(null)
    setAppState("idle")
    setError(null)
  }

  const handleRetry = () => {
    setError(null)
    handleGenerate()
  }

  return (
    <div className="min-h-screen bg-background">
      <Header onOpenLibrary={() => setIsLibraryOpen(true)} />

      <main className="mx-auto max-w-3xl px-6 py-8 md:py-12">
        {/* Input Section - Always visible when not in success state */}
        {appState !== "success" && (
          <BriefInput
            value={briefText}
            onChange={setBriefText}
            onGenerate={handleGenerate}
            isLoading={appState === "loading"}
            researchDocuments={researchDocuments}
            selectedResearch={selectedResearch}
            onToggleResearch={handleToggleResearch}
            onSelectAllResearch={handleSelectAllResearch}
            onClearAllResearch={handleClearAllResearch}
            onAddResearchDocument={handleAddResearchDocument}
            onRemoveResearchDocument={handleRemoveResearchDocument}
          />
        )}

        {/* Empty State */}
        {appState === "idle" && !briefText && <EmptyState />}

        {/* Loading State */}
        {appState === "loading" && <LoadingSkeleton />}

        {/* Error State */}
        {appState === "error" && error && (
          <div className="mt-8">
            <Alert variant="destructive">
              <AlertCircle className="h-4 w-4" />
              <AlertTitle>Generation Failed</AlertTitle>
              <AlertDescription className="mt-2">
                {error}
              </AlertDescription>
            </Alert>
            <div className="mt-4 flex gap-3">
              <Button onClick={handleRetry}>Try Again</Button>
              <Button variant="outline" onClick={handleReset}>
                Start Over
              </Button>
            </div>
          </div>
        )}

        {/* Success State - Results */}
        {appState === "success" && result && (
          <ResultsSection
            result={result}
            formats={formats}
            onReset={handleReset}
          />
        )}
      </main>

      {/* Format Library Modal */}
      <FormatLibrary
        isOpen={isLibraryOpen}
        onClose={() => setIsLibraryOpen(false)}
        formats={formats}
        onUpdateFormats={handleUpdateFormats}
        diagnosticRules={diagnosticRules}
        onUpdateRules={handleUpdateRules}
      />
    </div>
  )
}
